Xeris Biopharma Holdings Inc (XERS)
3.47
+0.05
(+1.46%)
USD |
NASDAQ |
Dec 24, 12:29
Xeris Biopharma Holdings Market Cap: 517.31M for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Zevra Therapeutics Inc | 457.43M |
NovaBay Pharmaceuticals Inc | 2.625M |
Palatin Technologies Inc | 18.75M |
iBio Inc | 22.32M |
Theriva Biologics Inc | 4.674M |
Market Cap Related Metrics
PS Ratio | 2.667 |
Price | 3.47 |
Earnings Yield | -12.68% |